A bill to amend the Federal Food, Drug, and Cosmetic Act, as amended, to prohibit the use of any name in connection with any prescription drug other than the official name designated for such drug by the Secretary of Health, Education, and Welfare.

Provides, under the Federal Food, Drug, and Cosmetic Act, that the Secretary of Health, Education, and Welfare shall designate an official name for any new drug subject to prescription sale upon approval of an application filed for such drug. Requires the Secretary to designate an official name for all drugs subject to prescription sale.

Requires that such official names shall, to the extent possible, be in the interest of usefulness and simplicity and designed to adequately and fully replace the use of trade, brand, or proprietary names. (Amends 21 U.S.C. 358(a))